{"entity":{"id":"nct07042802","kind":"trial","name":"A Study of LBL-024 in Combination With Paclitaxel ± Bevacizumab for the Treatment of Platinum-resistant Ovarian Cancer","aka":[],"tldr":"A phase 1/2 trial of Paclitaxel / nab-paclitaxel, Bevacizumab in ovarian cancer, run by Nanjing Leads Biolabs Co.,Ltd, now recruiting.","summary":"A Study of LBL-024 in Combination With Paclitaxel ± Bevacizumab for the Treatment of Platinum-resistant Ovarian Cancer is a phase 1/2 interventional study registered as NCT07042802 by Nanjing Leads Biolabs Co.,Ltd, with 180 participants planned, started 2025-12-02 and due to reach its primary completion in 2027-12-25. Interventions recorded: LBL-024 for Injection, Paclitaxel injection, Bevacizumab injection. Conditions listed: Ovarian Cancer. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT07042802","url":"https://clinicaltrials.gov/study/NCT07042802"}],"tags":["ctgov-ingest"],"related":[],"cancers":["ovarian"],"sections":[],"technologies":[],"targets":[],"drugs":["paclitaxel","bevacizumab"],"companies":["nanjing-leads-biolabs"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT07042802","phase":"1/2","setting":"An Open-label, Multi-center Phase Ib/II Study to Evaluate the Efficacy and Safety of LBL-024 in Combination With Paclitaxel Injection ± Bevacizumab in Patients With Platinum-resistant Ovarian Cancer","sponsor":"Nanjing Leads Biolabs Co.,Ltd","enrolled":180,"outcomes":[]},"route":"/trials/nct07042802/","neighbours":{"cancer":[{"id":"ovarian","kind":"cancer","name":"Ovarian cancer","route":"/cancers/ovarian/"}],"drug":[{"id":"bevacizumab","kind":"drug","name":"Bevacizumab","route":"/drugs/bevacizumab/"},{"id":"paclitaxel","kind":"drug","name":"Paclitaxel / nab-paclitaxel","route":"/drugs/paclitaxel/"}],"company":[{"id":"nanjing-leads-biolabs","kind":"company","name":"Nanjing Leads Biolabs","route":"/companies/nanjing-leads-biolabs/"}]}}